Article Versions Notes

Deguchi S, Ogata F, Watanabe M, Otake H, Yamamoto N, Kawasaki N, Nagai N. Nanocrystalline Suspensions of Irbesartan Enhance Oral Bioavailability by Improving Drug Solubility and Leading Endocytosis Uptake into the Intestine. Pharmaceutics. 2021; 13(9):1404. https://doi.org/10.3390/pharmaceutics13091404

Deguchi, Saori, Fumihiko Ogata, Masaki Watanabe, Hiroko Otake, Naoki Yamamoto, Naohito Kawasaki, and Noriaki Nagai. 2021. "Nanocrystalline Suspensions of Irbesartan Enhance Oral Bioavailability by Improving Drug Solubility and Leading Endocytosis Uptake into the Intestine" Pharmaceutics 13, no. 9: 1404. https://doi.org/10.3390/pharmaceutics13091404

Deguchi, S., Ogata, F., Watanabe, M., Otake, H., Yamamoto, N., Kawasaki, N., & Nagai, N. (2021). Nanocrystalline Suspensions of Irbesartan Enhance Oral Bioavailability by Improving Drug Solubility and Leading Endocytosis Uptake into the Intestine. Pharmaceutics, 13(9), 1404. https://doi.org/10.3390/pharmaceutics13091404